VPS37A and neoplasm: Furthermore, both the integrative multi-omics analysis and immunohistochemical validation using our CRC patient cohort (Cohort 2) consistently confirmed that low VPS37A expression is significantly associated with advanced tumor stages and reduced overall survival in CRC.